Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Clerck

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Thrombosis Et Diathesis Haemorrhagica|October 31, 1972
Effect of lidoflazine (R 7904) on human platelet function in vitroF De Clerck
Agents and Actions|August 1, 1986
Blood platelets in human essential hypertensionF De Clerck
Clinical Physiology and Biochemistry|January 1, 1990
The role of serotonin in thrombogenesisF De Clerck
Acta Gastro-Enterologica Belgica|December 15, 2020
Longstanding gastrointestinal symptoms after COVID-19F de Clerck
Thrombosis and Haemostasis|October 21, 1986
S2-serotonergic receptor inhibition (ketanserin), combined with thromboxane A2/prostaglandin endoperoxide receptor blockade (BM 13.177): enhanced anti-platelet effectF De Clerck
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 1, 1982
Effects of pharmacological agents on erythrocyte deformability and endothelial cell injuryF De Clerck
Journal of Cardiovascular Pharmacology|January 1, 1991
Effects of serotonin on platelets and blood vesselsF De Clerck
The American Journal of Physiology|July 1, 1993
5-Hydroxytryptamine dominates over thromboxane A2 in reducing collateral blood flow by activated plateletsW Loots, F De Clerck
Angiology|July 1, 1981
Protection by flunarizine against endothelial cell injury in vivoJ Hladovec, F De Clerck
Agents and Actions|March 1, 1986
Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human platelets in vitroF De Clerck, B Xhonneux
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Thrombosis Et Diathesis Haemorrhagica|October 31, 1972
Effect of lidoflazine (R 7904) on human platelet function in vitroF De Clerck
Agents and Actions|August 1, 1986
Blood platelets in human essential hypertensionF De Clerck
Clinical Physiology and Biochemistry|January 1, 1990
The role of serotonin in thrombogenesisF De Clerck
Acta Gastro-Enterologica Belgica|December 15, 2020
Longstanding gastrointestinal symptoms after COVID-19F de Clerck
Thrombosis and Haemostasis|October 21, 1986
S2-serotonergic receptor inhibition (ketanserin), combined with thromboxane A2/prostaglandin endoperoxide receptor blockade (BM 13.177): enhanced anti-platelet effectF De Clerck
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 1, 1982
Effects of pharmacological agents on erythrocyte deformability and endothelial cell injuryF De Clerck
Journal of Cardiovascular Pharmacology|January 1, 1991
Effects of serotonin on platelets and blood vesselsF De Clerck
The American Journal of Physiology|July 1, 1993
5-Hydroxytryptamine dominates over thromboxane A2 in reducing collateral blood flow by activated plateletsW Loots, F De Clerck
Angiology|July 1, 1981
Protection by flunarizine against endothelial cell injury in vivoJ Hladovec, F De Clerck
Agents and Actions|March 1, 1986
Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human platelets in vitroF De Clerck, B Xhonneux
Pageof 14